These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14580402)

  • 1. Duplex PCR-RFLP for simultaneous detection of factor V Leiden and prothrombin G20210A.
    Lucotte G; Champenois T
    Mol Cell Probes; 2003 Oct; 17(5):267-9. PubMed ID: 14580402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
    Koksal V; Baris I; Etlik O
    Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex PCR-RFLP assay for detection of factor V Leiden and prothrombin G20210A.
    Baris I; Koksal V; Etlik O
    Genet Test; 2004; 8(4):381-3. PubMed ID: 15684866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden detection by polymerase chain reaction-restriction fragment length polymorphism with mutagenic primers in a multiplex reaction with Pro G20210A--a novel technique.
    Welbourn JT; Maiti S; Paley J
    Hematology; 2003 Apr; 8(2):73-5. PubMed ID: 12745655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.
    Rahimi Z; Vaisi-Raygani A; Mozafari H; Kharrazi H; Rezaei M; Nagel RL
    J Thromb Thrombolysis; 2008 Jun; 25(3):280-3. PubMed ID: 17700999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutations.
    Maher C; Crowley D; Cullen C; Wall C; Royston D; Fanning S
    Thromb Haemost; 1999 Jan; 81(1):76-80. PubMed ID: 9974379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms.
    Linfert DR; Tsongalis GJ
    Diagn Mol Pathol; 2001 Jun; 10(2):111-5. PubMed ID: 11385320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study.
    Ahmed NA; Adam I; Elzaki SEG; Awooda HA; Hamdan HZ
    BMC Med Genet; 2019 Jan; 20(1):2. PubMed ID: 30611230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous polymerase chain reaction restriction fragment length polymorphism identification of the factor V Leiden allele and the prothrombin 20210A mutation.
    Wisotzkey JD; Bell T; Monk JS
    Diagn Mol Pathol; 1998 Jun; 7(3):180-3. PubMed ID: 9836075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex PCR for the detection of the factor V Leiden and prothrombin 20210A mutations.
    Sproul AM; Chalmers EA
    Methods Mol Med; 2004; 91():79-87. PubMed ID: 14573931
    [No Abstract]   [Full Text] [Related]  

  • 16. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.
    Almawi WY; Keleshian SH; Borgi L; Fawaz NA; Abboud N; Mtiraoui N; Mahjoub T
    J Thromb Thrombolysis; 2005 Dec; 20(3):163-8. PubMed ID: 16261289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined factor V leiden (G1691A) and prothrombin (G20210A) genotyping by multiplex real-time polymerase chain reaction using fluorescent resonance energy transfer hybridization probes on the Rotor-Gene 2000.
    Ameziane N; Lamotte M; Lamoril J; Lebret D; Deybach JC; Kaiser T; de Prost D
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):421-4. PubMed ID: 12945887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism.
    Shafia S; Zargar MH; Khan N; Ahmad R; Shah ZA; Asimi R
    Gene; 2018 May; 654():1-9. PubMed ID: 29454086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
    Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous allele-specific amplification: a strategy using modified primer-template mismatches for SNP detection--application to prothrombin 20210A (factor II) and factor V Leiden (1691A) gene mutations.
    DelRio-LaFreniere SA; McGlennen RC
    Mol Diagn; 2001 Sep; 6(3):201-9. PubMed ID: 11571714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.